Cargando…
Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
Alzheimer’s disease (AD) is the prime cause of 65–80% of dementia cases and is caused by plaque and tangle deposition in the brain neurons leading to brain cell degeneration. β-secretase (BACE-1) is a key enzyme responsible for depositing extracellular plaques made of β-amyloid protein. Therefore, e...
Autores principales: | Bhatia, Shiveena, Singh, Manjinder, Sharma, Pratibha, Mujwar, Somdutt, Singh, Varinder, Mishra, Krishna Kumar, Singh, Thakur Gurjeet, Singh, Tanveer, Ahmad, Sheikh Fayaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459662/ https://www.ncbi.nlm.nih.gov/pubmed/37630283 http://dx.doi.org/10.3390/molecules28166032 |
Ejemplares similares
-
Computational Studies to Understand the Neuroprotective Mechanism of Action Basil Compounds
por: Singh, Varinder, et al.
Publicado: (2023) -
In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β)
por: Goyal, Shuchi, et al.
Publicado: (2023) -
Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development
por: Bhatia, Shiveena, et al.
Publicado: (2022) -
Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
por: Sharma, Pratibha, et al.
Publicado: (2023) -
From the Desk of the Editor … The new dawn - Hope in the pandemic
por: Singh, Shishir
Publicado: (2020)